Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 7 | Anderson RaymondDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | $42K 1,402 sh | Nov 4, 2026 |
| 7 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $14K 382 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Tang StanleyDirector | DASHDoorDash, Inc. Other acquisition or disposition · 10b5-1 plan | J | — 23.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $2.22M 170.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 7 | Zage George Raymond IIIDirector, 10% Owner | GRNDGrindr Inc. Open-market sale · 10b5-1 plan | SELL | $4.22M 330.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 7 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | $28K 2,035 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 7 | Wassenaar YvonneDirector | RBRKRubrik, Inc. Derivative conversion · 10b5-1 plan | C | — 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $162K 522 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $205K 1,730 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $91K 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 2,087 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $79K 658 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $160K 1,375 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 336 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nithrakashyap ArvindDirector, Chief Technology Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 699 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $224K 15.0K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 6 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $51K 147 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Sieffert Kristen NPresident |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $7,897 750 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $218K 708 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $152K 490 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $162K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $89K 280 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $140K 440 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $102K 320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $166K 480 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Merriman Dwight ADirector | MDBMongoDB, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 320 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Felice Laura L.EVP, Chief Financial Officer |  BJBJ's Wholesale Club Holdings, Inc.Option exercise · 10b5-1 plan | M | $170K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $42K 1,268 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $64K 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Amara CarmenChief People Officer |  YELPYELP INCOpen-market sale · 10b5-1 plan | SELL | $9,605 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $225K 920 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $163K 675 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | $59K 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $93K 500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $121K 480 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $126K 403 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $198K 634 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Nonko EugeneDirector | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 5,667 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 6 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 343 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $227K 933 sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K